{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T06:01:13Z","timestamp":1784959273396,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-026-01423-y","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:28:44Z","timestamp":1784957324000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GATA6-mediated transcriptional activation and METTL3\/IGF2BP2-dependent post-transcriptional stabilization upregulate CDC20 to promote the malignant progression of colorectal cancer and immune escape"],"prefix":"10.1007","volume":"39","author":[{"given":"Yuyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiyuan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohe","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"issue":"3","key":"1423_CR1","first-page":"233","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233\u201354.","journal-title":"CA Cancer J Clin"},{"key":"1423_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/bjsopen\/zrae038","author":"HG Smith","year":"2024","unstructured":"Smith HG, Nilsson PJ, Shogan BD, Harji D, Gambacorta MA, Romano A, et al. Neoadjuvant treatment of colorectal cancer: comprehensive review. BJS Open. 2024. https:\/\/doi.org\/10.1093\/bjsopen\/zrae038.","journal-title":"BJS Open"},{"key":"1423_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154837","volume":"251","author":"Y Ni","year":"2023","unstructured":"Ni Y, Liang Y, Li M, Lin Y, Zou X, Han F, et al. The updates on metastatic mechanism and treatment of colorectal cancer. Pathol Res Pract. 2023;251:154837.","journal-title":"Pathol Res Pract"},{"issue":"4","key":"1423_CR4","doi-asserted-by":"publisher","first-page":"340","DOI":"10.2174\/0118744710331660250127115004","volume":"18","author":"B Ensiyeh","year":"2025","unstructured":"Ensiyeh B, Yazdan Z, Ali H, Manijeh J, Sahar M. Role of the p53\/miR-34a\/SIRT1 feedback loop in metformin-induced radiosensitivity of colorectal cancer cells. Curr Radiopharm. 2025;18(4):340\u201351.","journal-title":"Curr Radiopharm"},{"key":"1423_CR5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI178331","author":"D Wolf","year":"2024","unstructured":"Wolf D, Salcher S, Pircher A. The multivisceral landscape of colorectal cancer metastasis: implications for targeted therapies. J Clin Invest. 2024. https:\/\/doi.org\/10.1172\/JCI178331.","journal-title":"J Clin Invest"},{"issue":"3","key":"1423_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.21147\/j.issn.1000-9604.2023.03.01","volume":"35","author":"N Association","year":"2023","unstructured":"Association N. National Health Commission guidelines for diagnosis and treatment of colorectal cancer 2023 in China (English version). Chin J Cancer Res. 2023;35(3):197\u2013232.","journal-title":"Chin J Cancer Res"},{"key":"1423_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2023.147857","volume":"892","author":"M Housini","year":"2024","unstructured":"Housini M, Dariya B, Ahmed N, Stevens A, Fiadjoe H, Nagaraju GP, et al. Colorectal cancer: genetic alterations, novel biomarkers, current therapeutic strategies and clinical trials. Gene. 2024;892:147857.","journal-title":"Gene"},{"issue":"1","key":"1423_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12943-023-01841-8","volume":"22","author":"SW Yue","year":"2023","unstructured":"Yue SW, Liu HL, Su HF, Luo C, Liang HF, Zhang BX, et al. M6A-regulated tumor glycolysis: new advances in epigenetics and metabolism. Mol Cancer. 2023;22(1):137.","journal-title":"Mol Cancer"},{"issue":"1","key":"1423_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.curpro.2025.100001","volume":"22","author":"Z Wu","year":"2025","unstructured":"Wu Z, Shen N, Song P, Wang B, Li C. SP1-mediated WTAP exacerbates the progression of colon adenocarcinoma by m6A methylation of KLK8. Curr Proteomics. 2025;22(1):100001.","journal-title":"Curr Proteomics"},{"issue":"12","key":"1423_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s12032-022-01827-4","volume":"39","author":"H Qiao","year":"2022","unstructured":"Qiao H, Liu L, Chen J, Shang B, Wang L. The functions of N6-methyladenosine (m6A) RNA modifications in colorectal cancer. Med Oncol (Northwood, London, England). 2022;39(12):235.","journal-title":"Med Oncol (Northwood, London, England)"},{"key":"1423_CR11","doi-asserted-by":"publisher","DOI":"10.3892\/or.2021.7987","author":"F Liu","year":"2021","unstructured":"Liu F, Su X. Effects of m6A modifications on signaling pathways in human cancer (Review). Oncol Rep. 2021. https:\/\/doi.org\/10.3892\/or.2021.7987.","journal-title":"Oncol Rep"},{"issue":"1","key":"1423_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","volume":"21","author":"Y An","year":"2022","unstructured":"An Y, Duan H. The role of m6A RNA methylation in cancer metabolism. Mol Cancer. 2022;21(1):14.","journal-title":"Mol Cancer"},{"issue":"2","key":"1423_CR13","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.molcel.2016.05.041","volume":"63","author":"P Wang","year":"2016","unstructured":"Wang P, Doxtader KA, Nam Y. Structural basis for cooperative function of Mettl3 and Mettl14 methyltransferases. Mol Cell. 2016;63(2):306\u201317.","journal-title":"Mol Cell"},{"issue":"4","key":"1423_CR14","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1053\/j.gastro.2022.06.024","volume":"163","author":"H Chen","year":"2022","unstructured":"Chen H, Pan Y, Zhou Q, Liang C, Wong CC, Zhou Y, et al. METTL3 inhibits antitumor immunity by targeting m(6)A-BHLHE41-CXCL1\/CXCR2 axis to promote colorectal cancer. Gastroenterology. 2022;163(4):891\u2013907.","journal-title":"Gastroenterology"},{"issue":"1","key":"1423_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13046-021-02227-8","volume":"41","author":"J Pan","year":"2022","unstructured":"Pan J, Liu F, Xiao X, Xu R, Dai L, Zhu M, et al. METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis. J Exp Clin Cancer Res. 2022;41(1):19.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"1423_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2024.101353","volume":"12","author":"M Ma","year":"2025","unstructured":"Ma M, An J, Jiang T, Xie K. GATA6 in pancreatic cancer initiation and progression. Genes Dis. 2025;12(2):101353.","journal-title":"Genes Dis"},{"issue":"6","key":"1423_CR17","first-page":"751","volume":"21","author":"W Lixiang","year":"2024","unstructured":"Lixiang W, Junhong L, Daopei Z, Huailiang Z. Serum proteomics reveals differential proteins between individuals with vestibular migraine and healthy subjects. Curr Proteomics. 2024;21(6):751\u20139.","journal-title":"Curr Proteomics"},{"key":"1423_CR18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI156305","author":"Z Zhong","year":"2022","unstructured":"Zhong Z, Harmston N, Wood KC, Madan B, Virshup DM. A p300\/GATA6 axis determines differentiation and Wnt dependency in pancreatic cancer models. J Clin Invest. 2022. https:\/\/doi.org\/10.1172\/JCI156305.","journal-title":"J Clin Invest"},{"issue":"1","key":"1423_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s13577-023-00987-3","volume":"37","author":"F Gao","year":"2024","unstructured":"Gao F, Wu Q, Lu D. MicroRNA-10a-5p-mediated downregulation of GATA6 inhibits tumor progression in ovarian cancer. Hum Cell. 2024;37(1):271\u201384.","journal-title":"Hum Cell"},{"issue":"6","key":"1423_CR20","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ads4985","volume":"11","author":"H Lyu","year":"2025","unstructured":"Lyu H, Chen X, Cheng Y, Zhang T, Wang P, Wong JH, et al. Pioneer factor GATA6 promotes colorectal cancer through 3D genome regulation. Sci Adv. 2025;11(6):eads4985.","journal-title":"Sci Adv"},{"issue":"2","key":"1423_CR21","first-page":"678","volume":"15","author":"W He","year":"2023","unstructured":"He W, Meng J. CDC20: a novel therapeutic target in cancer. Am J Transl Res. 2023;15(2):678\u201393.","journal-title":"Am J Transl Res"},{"issue":"5","key":"1423_CR22","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s12282-021-01242-z","volume":"28","author":"C Song","year":"2021","unstructured":"Song C, Lowe VJ, Lee S. Inhibition of Cdc20 suppresses the metastasis in triple negative breast cancer (TNBC). Breast Cancer. 2021;28(5):1073\u201386.","journal-title":"Breast Cancer"},{"key":"1423_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111577","volume":"127","author":"X Zhang","year":"2025","unstructured":"Zhang X, Bi F, Yang Q. Mechanism underlying CDC20 affecting epithelial ovarian cancer biological behavior by regulating BAG6 ubiquitination. Cell Signal. 2025;127:111577.","journal-title":"Cell Signal"},{"key":"1423_CR24","doi-asserted-by":"publisher","DOI":"10.2174\/0109298673360490250225230115","author":"D Li","year":"2025","unstructured":"Li D, Lyu G. Decoding colorectal cancer: key genes and pathways in the Chinese population revealed. Curr Med Chem. 2025. https:\/\/doi.org\/10.2174\/0109298673360490250225230115.","journal-title":"Curr Med Chem"},{"issue":"3","key":"1423_CR25","first-page":"229","volume":"74","author":"F Bray","year":"2022","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2022;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"1423_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.curpro.2025.100049","volume":"22","author":"F Mou","year":"2025","unstructured":"Mou F, Sun Q, Ye Z. Advances in the combination of immunotherapy and radiotherapy for microsatellite-stable metastatic colorectal cancer. Curr Proteomics. 2025;22(5):100049.","journal-title":"Curr Proteomics"},{"issue":"1","key":"1423_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-64726-w","volume":"14","author":"W Tian","year":"2024","unstructured":"Tian W, Zhao J, Zhang X, Li P, Li X, Hong Y, et al. RUNX1 regulates MCM2\/CDC20 to promote COAD progression modified by deubiquitination of USP31. Sci Rep. 2024;14(1):13906.","journal-title":"Sci Rep"},{"key":"1423_CR28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/1479-5876-11-142","volume":"11","author":"WJ Wu","year":"2013","unstructured":"Wu WJ, Hu KS, Wang DS, Zeng ZL, Zhang DS, Chen DL, et al. CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer. J Transl Med. 2013;11:142.","journal-title":"J Transl Med"},{"issue":"1","key":"1423_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12957-020-01817-8","volume":"18","author":"J Li","year":"2020","unstructured":"Li J, Wang Y, Wang X, Yang Q. CDK1 and CDC20 overexpression in patients with colorectal cancer are associated with poor prognosis: evidence from integrated bioinformatics analysis. World J Surg Oncol. 2020;18(1):50.","journal-title":"World J Surg Oncol"},{"key":"1423_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186692","author":"Y Gao","year":"2020","unstructured":"Gao Y, Wen P, Chen B, Hu G, Wu L, Xu A, et al. Downregulation of CDC20 increases radiosensitivity through Mcl-1\/p-Chk1-mediated DNA damage and apoptosis in tumor cells. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21186692.","journal-title":"Int J Mol Sci"},{"issue":"Pt 3","key":"1423_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.semcancer.2022.05.009","volume":"86","author":"D Ramesh-Kumar","year":"2022","unstructured":"Ramesh-Kumar D, Guil S. The IGF2BP family of RNA binding proteins links epitranscriptomics to cancer. Semin Cancer Biol. 2022;86(Pt 3):18\u201331.","journal-title":"Semin Cancer Biol"},{"issue":"11","key":"1423_CR32","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/s41419-023-06287-w","volume":"14","author":"Y Sun","year":"2023","unstructured":"Sun Y, Gong W, Zhang S. METTL3 promotes colorectal cancer progression through activating JAK1\/STAT3 signaling pathway. Cell Death Dis. 2023;14(11):765.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1423_CR33","first-page":"111","volume":"43","author":"P Ouyang","year":"2024","unstructured":"Ouyang P, Li K, Xu W, Chen C, Shi Y, Tian Y, et al. METTL3 recruiting M2-type immunosuppressed macrophages by targeting m6A-SNAIL-CXCL2 axis to promote colorectal cancer pulmonary metastasis. J Exp Clin Cancer Res CR. 2024;43(1):111.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"1423_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184413","author":"SM Ferrari","year":"2019","unstructured":"Ferrari SM, Fallahi P, Galdiero MR, Ruffilli I, Elia G, Ragusa F, et al. Immune and inflammatory cells in thyroid cancer microenvironment. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20184413.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1423_CR35","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1158\/2159-8290.CD-20-1680","volume":"11","author":"P Sharma","year":"2021","unstructured":"Sharma P, Siddiqui BA, Anandhan S, Yadav SS, Subudhi SK, Gao J, et al. The next decade of immune checkpoint therapy. Cancer Discov. 2021;11(4):838\u201357.","journal-title":"Cancer Discov"},{"key":"1423_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.840029","volume":"13","author":"S Wang","year":"2022","unstructured":"Wang S, Liu G, Li Y, Pan Y. Metabolic reprogramming induces macrophage polarization in the tumor microenvironment. Front Immunol. 2022;13:840029.","journal-title":"Front Immunol"},{"key":"1423_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2025.112171","volume":"136","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Wang H, Li K, Xu X, Yan Q, Sun Y, et al. APC\/C coactivators Cdh1 and Cdc20: mechanistic insights into cancer progression and therapeutic opportunities. Cell Signal. 2025;136:112171.","journal-title":"Cell Signal"},{"key":"1423_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-026-06926-0","author":"Y Chen","year":"2026","unstructured":"Chen Y, Yang P, Gao S, Liu S, Wang J, Zhang W, et al. Inhibition of CDC20 suppresses the development and progression of mantle cell lymphoma through PI3K\/AKT pathway. Ann Hematol. 2026. https:\/\/doi.org\/10.1007\/s00277-026-06926-0.","journal-title":"Ann Hematol"},{"issue":"13","key":"1423_CR39","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.7150\/jca.77619","volume":"13","author":"Z Quan","year":"2022","unstructured":"Quan Z, Yang Y, Zheng H, Zhan Y, Luo J, Ning Y, et al. Clinical implications of the interaction between PD-1\/PD-L1 and PI3K\/AKT\/mTOR pathway in progression and treatment of non-small cell lung cancer. J Cancer. 2022;13(13):3434\u201343.","journal-title":"J Cancer"},{"issue":"1","key":"1423_CR40","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1186\/s12951-024-02888-5","volume":"22","author":"Z Xue","year":"2024","unstructured":"Xue Z, Liu J, Xing W, Mu F, Wu Y, Zhao J, et al. Hypoxic glioma-derived exosomal miR-25-3p promotes macrophage M2 polarization by activating the PI3K-AKT-mTOR signaling pathway. J Nanobiotechnol. 2024;22(1):628.","journal-title":"J Nanobiotechnol"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01423-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-026-01423-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01423-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:28:45Z","timestamp":1784957325000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-026-01423-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["1423"],"URL":"https:\/\/doi.org\/10.1007\/s13577-026-01423-y","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All human disease tissue research was approved by the Institutional Review Board of the First Affiliated Hospital of Henan Medical University (Approval No.:EC-LW26-097), and complied with the Declaration of Helsinki. Written informed consent was obtained from all patients, and all samples were de-identified to protect patient privacy.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consents were obtained from all participants.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All nude mouse xenograft experiments were approved by the Institutional Animal Care and Use Committee of the First Affiliated Hospital of Henan Medical University (Approval No.:EC-DW026-022). Animal procedures followed the ARRIVE guidelines and 3Rs principle. Anesthesia was used in all surgeries, and humane euthanasia was applied to reduce animal distress, which fully complied with relevant ethical standards.","order":4,"name":"Ethics","label":"Animal studies","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"115"}}